Summer Street says that after speaking with medical professionals, is appears that Onyx Pharmaceuticals (ONXX +0.4%) myeloma drug Kyprolis may be used in earlier stage treatments . Dr. Ravi Vij, associate professor at the department of Medicine at Washington University, told analysts at the firm that he hopes to use the drug on the majority of his 3rd-line or higher patients, and possibly even 2nd-line patients if he doesn’t get pushback on reimbursement.